Lannett To Launch Into Congested ADHD Market

Lines Up Latest Rival To Adderall XR

 
• By Aidan Fry

Lannett expects soon to launch a generic rival to Adderall XR following FDA approval for its partner SunGen. But the US generics specialist will face considerable competition.

Adderall
Lannett is poised to be the latest company offering a US generic rival to Adderall XR • Source: Shutterstock

More from Products

More from Generics Bulletin